skip to main content
Hide All The Ads With a Yearly Membership Subscribe ▶

H.R. 733 (112th): Recalcitrant Cancer Research Act of 2012

Call or Write Congress

React to this bill with an emoji

(About Ads | Hide These Ads)

To provide for scientific frameworks with respect to recalcitrant cancers.

The bill’s titles are written by its sponsor.

Sponsor and status

Photo of sponsor Anna Eshoo

Anna Eshoo

Sponsor. Representative for California's 14th congressional district. Democrat.

Thumbnail of bill text
Read Text »
Last Updated: Sep 20, 2012
Length: 9 pages
Introduced
Feb 16, 2011
112th Congress (2011–2013)
Status
Enacted Via Other Measures

Provisions of this bill were incorporated into other bills which were enacted.

This bill was incorporated into:

H.R. 4310: National Defense Authorization Act for Fiscal Year 2013
Enacted — Signed by the President on Jan 2, 2013. (compare text)
Cosponsors

294 Cosponsors (181 Democrats, 113 Republicans)

Source
Congress.gov
(About Ads | Hide These Ads)

History

Feb 16, 2011
 
Introduced

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

Read Text »

May 18, 2012
 
Final Bill — Passed House (Senate next)

This activity took place on a related bill, H.R. 4310 (112th), possibly in lieu of similar activity on H.R. 733 (112th).
Sep 19, 2012
 
Passed House (Senate next)

The bill was passed in a vote in the House. It goes to the Senate next. The vote was by voice vote so no record of individual votes was made.

Read Updated Text » See Changes »

Dec 4, 2012
 
Final Bill — Passed Senate with Changes (back to House)

This activity took place on a related bill, H.R. 4310 (112th), possibly in lieu of similar activity on H.R. 733 (112th).
Dec 12, 2012
 
Final Bill — Passed Senate with Changes (back to House)

This activity took place on a related bill, H.R. 4310 (112th), possibly in lieu of similar activity on H.R. 733 (112th).
Dec 20, 2012
 
Final Bill — Conference Report Agreed to by House (Senate next)

This activity took place on a related bill, H.R. 4310 (112th), possibly in lieu of similar activity on H.R. 733 (112th).
Dec 21, 2012
 
Final Bill — Conference Report Agreed to by Senate

This activity took place on a related bill, H.R. 4310 (112th), possibly in lieu of similar activity on H.R. 733 (112th).
Jan 2, 2013
 
Final Bill — Enacted — Signed by the President

This activity took place on a related bill, H.R. 4310 (112th), possibly in lieu of similar activity on H.R. 733 (112th).

H.R. 733 (112th) was a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

Bills numbers restart every two years. That means there are other bills with the number H.R. 733. This is the one from the 112th Congress.

This bill was introduced in the 112th Congress, which met from Jan 5, 2011 to Jan 3, 2013. Legislation not passed by the end of a Congress is cleared from the books.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“H.R. 733 — 112th Congress: Recalcitrant Cancer Research Act of 2012.” www.GovTrack.us. 2011. May 15, 2024 <https://www.govtrack.us/congress/bills/112/hr733>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.